Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in out-of-hospital cardiac arrest
ISRCTN15862521Phase 2Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Survival at day 30. Started Apr 2026; status: recruiting.
02
Drugs
levosimendan
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on ISRCTN15862521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15862521.